J ADV RES
| WoS 期刊 JCR 分区 (2026 · JIF) | 综合 SCIE | Q1 | ||
|---|---|---|---|---|
| 学科 | 收录集 | JIF 分区 | JIF 排名 | JIF 百分位 |
| 综合性学科 Multidisciplinary Sciences | SCIE | Q1 | 11/140 |
92.1%
|
| 学科 | 收录集 | JCI 分区 | JCI 排名 | JCI 百分位 |
|---|---|---|---|---|
| 综合性学科 Multidisciplinary Sciences | SCIE | Q1 | 8/103 JCI 2.63 |
93.2%
|
The Journal of Advanced Research (J Adv Res, ISSN: 2090-1232) is a premier, peer-reviewed, open-access journal published by Elsevier on behalf of Cairo University. With an exceptional 2026 Impact Factor of 17.100, it is firmly positioned in the top tier (Q1) of the Journal Citation Reports, reflecting its status as one of the most influential multidisciplinary scientific platforms globally. The journal’s scope is broad yet rigorous, encompassing cutting-edge research across the full spectrum of the natural and applied sciences, with a particular emphasis on medicine, pharmacology, engineering, biotechnology, environmental science, and agricultural sciences. It serves as a high-impact venue for groundbreaking studies that bridge fundamental discoveries with practical applications. The journal accepts a variety of article types, including original full-length research articles, comprehensive review articles, short communications, and case reports, all of which undergo stringent single-blind peer review to ensure methodological soundness and novelty. The primary target audience includes academic researchers, postdoctoral fellows, graduate students, and industry professionals seeking to stay at the forefront of interdisciplinary scientific advancement. A notable feature of the Journal of Advanced Research is its full open-access model, ensuring that all published content is freely and permanently available online, which maximizes visibility and citation potential for authors. Its combination of a very high impact factor, Q1 ranking, and broad thematic coverage makes it a highly selective and respected outlet for disseminating significant scientific discoveries that have the potential to influence policy, clinical practice, and further research.